LitAlert ~~ GeneLit.com

Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic.
Zimovjanova M, Bielcikova Z, Miskovicova M, Vocka M, Zimovjanova A, Marian Rybar M, Novotny J, Petruzelka L.
Cancers (Basel). 2023 Feb 8;15(4):1072. doi: 10.3390/cancers15041072.

Combining Breast Cancer Risk Prediction Models.
Guan Z, Huang T, McCarthy AM, Hughes K, Semine A, Uno H, Trippa L, Parmigiani G, Braun D.
Cancers (Basel). 2023 Feb 8;15(4):1072. doi: 10.3390/cancers15041090.

Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes.
D’Elia G, Caliendo G, Passariello L, Albanese L, Makker J, Molinari AM, Vietri MT.
Genes (Basel). 2023 Feb 8;14(2):428. doi: 10.3390/genes14020428.

Role of psychological background in cancer susceptibility genetic testing distress: It is not only about a positive result.
López-Fernández A, Villacampa G, Salinas M, Grau E, Darder E, Carrasco E, Solanes A, Velasco A, Torres M, Munté E, Iglesias S, Torres-Esquius S, Tuset N, Diez O, Lázaro C, Brunet J, Corbella S, Balmaña J.
J Genet Couns. 2023 Feb 7. doi: 10.1002/jgc4.1687. Epub ahead of print.

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.
Tuninetti V, Ghisoni E, Pignata S, Picardo E, Raspagliesi F, Andreetta C, Maldi E, Artioli G, Mammoliti S, Zanchi L, Sikokis A, Biglia N, Parisi A, Mandato VD, Carella C, Cormio G, Marinaccio M, Puppo A, Paolini B, Borsotti L, Scotto G, Turinetto M, Sangiolo D, Di Maio M, Valabrega G.
Cancers (Basel). 2023 Feb 6;15(4):1032. doi: 10.3390/cancers15041032.

Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels.
Chang EY, Solomon I, Culver JO, Gorman N, Comeaux JG, Lerman C, Quinn EA, Ekstein T.
J Genet Couns. 2023 Feb 6. doi: 10.1002/jgc4.1680. Epub ahead of print.